Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 14.11.2024
Capricor Therapeutics Мультипликаторы 2011-2024 | CAPR
Мультипликаторы по годам Capricor Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.0 | -3.7 | -4.1 | -7.5 | -0.7 | -1.0 | 18.0 | -2.2 | -3.3 | -12.2 | -15.5 | -2.7 | -4.1 |
P/S |
6.2 | 42.5 | 336.6 | 330.2 | 5.7 | 9.2 | 16.4 | 10.1 | 7.7 | 15.9 | 273.4 | 25.9 | 14.6 |
EPS |
-0.8 | -1.2 | -0.9 | -0.9 | -2.1 | -5.2 | 0.1 | -1.0 | -0.8 | -0.5 | -0.8 | -0.0 | -0.1 |
EV (Enterprise Value) |
177 млн | 137 млн | 57.5 млн | 76.2 млн | 6.09 млн | 15.7 млн | 42.7 млн | 60 млн | 54 млн | 87.9 млн | 142 млн | 5.29 млн | 19.3 млн |
EBITDA per Share |
-0.86 | -1.19 | -0.9 | -0.87 | -2.04 | -5.16 | -5.48 | -9.08 | -7.86 | -5.11 | -6.55 | -28.8 | -65.5 |
EV/EBITDA |
-2.1 | -5.2 | -0.2 | -0.7 | -3.0 | -3.0 | -3.7 | -12.9 | -20.3 | -2.1 | -3.8 | ||
PEG |
0.32 | 0.21 | 0.13 | 0.1 | -0.01 | 0.0 | 0.16 | 0.09 | 0.06 | -0.32 | -0.27 | -0.04 | -0.13 |
P/B |
6.9 | 9.2 | 2.6 | 3.6 | 0.8 | 3.3 | 3.9 | -10.1 | -41.2 | -12.2 | -257.2 | -30.3 | 23.8 |
P/CF |
-6.1 | 22.1 | -4.9 | -9.7 | -0.8 | -1.1 | -3.1 | -2.5 | -3.9 | 98.5 | -22.0 | -2.3 | -4.3 |
ROE % |
-98.61 | -246.22 | -63.83 | -48.43 | -111.73 | -329.13 | 21.66 | 469.80 | 1246.14 | 99.49 | 1662.41 | 1131.43 | -588.02 |
ROA % |
-37.95 | -57.93 | -48.45 | -39.45 | -68.76 | -164.28 | 14.94 | -100.32 | -80.01 | -45.60 | -160.56 | -833.74 | -355.99 |
ROCE % |
-87.67 | -112.03 | -56.29 | -43.26 | -75.71 | -191.78 | -88.08 | -122.55 | -132.19 | -82.07 | -198.08 | 2347.89 | -589.75 |
Current Ratio |
1.6 | 1.3 | 4.1 | 11.3 | 11.7 | 6.7 | 9.4 | 3.7 | 2.1 | 1.8 | 1.8 | 0.5 | 2.4 |
DSO |
- | - | - | - | 31.9 | 44.7 | 47.2 | 20.4 | 14.0 | 27.5 | 0.1 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Capricor Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.38 | -0.35 | -0.31 | - | -0.25 | -0.29 | -0.31 | - | -0.26 | -0.29 | -0.32 | - | -0.17 | -0.21 | -0.23 | - | -0.2 | -0.23 | -0.3 | - | -0.43 | -0.59 | -0.75 | - | -1.35 | -1.42 | -0.14 | - | -0.12 | -0.16 | -0.17 | - | -0.29 | -0.26 | -0.26 | - | -0.18 | -0.19 | -0.23 | - | -0.13 | -0.13 | -0.1 | - | -0.15 | -0.16 | -0.14 | - | -0.01 | -0.01 | -0.02 | - | -0.03 | -0.03 | -0.03 |
EBITDA per Share |
-0.38 | -0.35 | -0.32 | - | -0.26 | -0.3 | -0.32 | - | -0.26 | -0.3 | -0.32 | - | -0.18 | -0.22 | -0.23 | - | -0.19 | -0.23 | -0.3 | - | -0.4 | -0.57 | -0.75 | - | -1.33 | -1.41 | -0.14 | - | -0.11 | -0.15 | -0.16 | - | -0.28 | -0.25 | -0.25 | - | -0.17 | -0.19 | -0.23 | - | -0.12 | -0.13 | -0.1 | - | -0.14 | -0.15 | -0.14 | - | -0.01 | -0.02 | -0.02 | - | -0.03 | -0.02 | -0.03 |
ROE % |
190.33 | 566.21 | 392.12 | -37.41 | -78.71 | -477.49 | -245.73 | -110.99 | -121.69 | -91.09 | -67.36 | -39.09 | -52.95 | -56.12 | -54.25 | -33.61 | -57.10 | -66.73 | -84.30 | -90.25 | -179.86 | -245.98 | -305.40 | -258.50 | -282.86 | -217.61 | -159.20 | -87.95 | 45.28 | 202.87 | 350.93 | 356.93 | 639.16 | 788.16 | 973.72 | 921.83 | 946.54 | 689.02 | 410.87 | 68.63 | 357.52 | 621.71 | 900.89 | 2255.03 | 3386.46 | 4229.01 | 5056.71 | 3394.30 | 2806.29 | 1086.84 | -632.61 | -1764.05 | -588.02 | -588.02 | -588.02 |
ROA % |
-79.26 | -82.95 | -70.22 | -47.63 | -59.45 | -54.06 | -50.29 | -36.10 | -45.22 | -42.53 | -42.18 | -32.85 | -44.14 | -46.31 | -44.49 | -27.38 | -41.84 | -45.00 | -53.35 | -55.54 | -100.27 | -130.54 | -156.72 | -129.03 | -145.83 | -117.91 | -94.65 | -60.67 | -89.12 | -100.76 | -104.44 | -76.22 | -94.34 | -84.01 | -78.43 | -59.19 | -70.51 | -63.72 | -55.54 | -31.46 | -59.36 | -75.94 | -94.02 | -217.80 | -1051.54 | -1857.38 | -2661.78 | -2501.22 | -2857.21 | -2379.46 | -1901.71 | -1067.97 | -355.99 | -355.99 | -355.99 |
ROCE % |
-297.71 | -442.21 | -440.77 | -282.72 | -303.80 | -162.43 | -110.08 | -55.56 | -66.32 | -56.00 | -50.82 | -37.56 | -49.92 | -51.53 | -48.73 | -30.05 | -45.98 | -49.55 | -58.75 | -61.19 | -113.39 | -149.66 | -181.53 | -150.42 | -168.48 | -134.34 | -105.39 | -65.62 | -103.44 | -123.21 | -133.37 | -101.52 | -131.40 | -123.45 | -122.24 | -97.76 | -118.01 | -108.39 | -96.49 | -56.61 | -99.48 | -122.10 | -148.25 | 178.56 | 523.01 | 910.34 | 1419.54 | 1267.45 | 1128.25 | 644.60 | 75.78 | -389.32 | -139.20 | -105.96 | -144.16 |
Current Ratio |
3.8 | 1.4 | 1.6 | 1.6 | 0.9 | 1.1 | 1.1 | 1.3 | 1.4 | 1.5 | 1.6 | 4.2 | 6.8 | 6.1 | 6.1 | 5.4 | 5.4 | 5.4 | 5.4 | 2.6 | 2.6 | 2.6 | 2.6 | 2.0 | 2.0 | 2.0 | 2.0 | 3.2 | 3.2 | 3.2 | 3.2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 | 0.9 | 0.9 | 0.9 | 10.2 | 0.6 | 0.6 | 0.6 | 2.5 | 2.5 | 2.5 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD